Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID01243931

Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy for Corneal Opacity

Led by Oregon Health and Science University · Updated on 2024-02-12

80

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

O

Oregon Health and Science University

Lead Sponsor

N

National Eye Institute (NEI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate whether using Optical Coherence Tomography (OCT) to guide laser settings during the removal of corneal scars and partial-thickness corneal defects can improve vision. The study focuses on patients with vision limited by superficial corneal opacities and irregularities that can be treated with phototherapeutic keratectomy (PTK). The project utilizes advanced Fourier-domain OCT technology to precisely measure corneal shape and guide surgery, aiming to restore vision by reshaping irregular corneas. The treatment involves OCT-guided laser phototherapeutic keratectomy, where preoperative OCT measurements help determine laser depth settings to remove anterior corneal opacities while preserving at least 250 microns of corneal stroma. The surgeon uses this detailed imaging to plan treatment parameters for precise removal. There is one experimental surgery arm using this OCT-assisted technique. Participants will undergo the PTK procedure guided by OCT data and will be followed for 12 months post-procedure. Researchers will assess improvements in best spectacle-corrected visual acuity (BSCVA) as the primary outcome, along with secondary measures including uncorrected visual acuity, refractive error, and higher order aberrations. The study includes regular visits for imaging and vision assessments to monitor outcomes and safety over the year following surgery.

CONDITIONS

Brief Title

Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with vision primarily limited by superficial corneal opacities and irregularities that can be removed by phototherapeutic keratectomy while preserving at least 250 microns of corneal stroma
Not Eligible

You will not qualify if you...

  • Inability to give informed consent
  • Inability to maintain stable fixation for OCT imaging
  • Inability to commit to required study visits
  • Presence of deep corneal opacities and irregularities
  • Presence of cataracts, retinal disease, glaucoma, or other eye conditions that may limit visual outcome after surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - 1 day

Participants undergo OCT-guided laser phototherapeutic keratectomy where high-speed OCT imaging guides the laser treatment to remove superficial corneal opacities while preserving corneal stroma.

1 surgical visit (in-person)

Post-operative Follow-up

Duration - Up to 12 months

Participants are monitored for improvements in visual acuity and corneal healing after surgery.

Multiple follow-up visits over 12 months

Trial Site Locations

Total: 1 location

1

Casey Eye Institute, Oregon Health & Science University

Portland, Oregon, United States, 97239

Actively Recruiting

Loading map...

Research Team

H

Humberto Martinez, COT

D

Denny Romfh, OD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Prospective, Multi-Center, Early Feasibility Study to Asse...

Corneal Opacity

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here